|
GB1187017A
(en)
*
|
1966-07-16 |
1970-04-08 |
Aspro Nicholas Ltd |
Substituted 1-Amino Indanes and Tetrahydronaphthalens
|
|
US3485874A
(en)
*
|
1966-05-04 |
1969-12-23 |
Chinoin Gyogyszer Es Vegyeszet |
Ortho and para bromophenyl isopropyl methylamines
|
|
US3852339A
(en)
*
|
1970-06-15 |
1974-12-03 |
Squibb & Sons Inc |
Aminoalkoxyphenylurea derivatives
|
|
FR2319332A1
(fr)
*
|
1975-07-28 |
1977-02-25 |
Roussel Uclaf |
Nouveaux derives de l'aminobenzocycloheptene et leurs sels, procede de preparation et application a titre de medicaments desdits produits
|
|
US4320148A
(en)
*
|
1980-11-24 |
1982-03-16 |
Smithkline Corporation |
2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
|
|
US4393226A
(en)
*
|
1981-05-06 |
1983-07-12 |
The Ohio State University Research Foundation |
Compounds and methods for changing calcium metabolism within the cells of a mammal
|
|
US4542153A
(en)
*
|
1981-05-06 |
1985-09-17 |
The Ohio State University Research Foundation |
Methods for changing calcium metabolism within the cells of a mammal
|
|
US5214156A
(en)
*
|
1988-03-25 |
1993-05-25 |
The Upjohn Company |
Therapeutically useful tetralin derivatives
|
|
IL93464A
(en)
*
|
1989-02-27 |
1996-10-16 |
Lilly Co Eli |
2-Amino-1,2,3,4-Tetrahydronaplanin and 3 aminochromes with a transformed ring, a process for their preparation and pharmaceutical preparations containing them
|
|
US5744500A
(en)
|
1990-01-03 |
1998-04-28 |
Teva Pharmaceutical Industries, Ltd. |
Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
|
|
IL92952A
(en)
*
|
1990-01-03 |
1994-06-24 |
Teva Pharma |
R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
|
|
US5844003A
(en)
*
|
1991-04-04 |
1998-12-01 |
Innovations Foundation |
Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
|
|
IL99759A
(en)
*
|
1991-10-16 |
1997-06-10 |
Teva Pharma |
Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them
|
|
JP4782252B2
(ja)
*
|
1994-01-10 |
2011-09-28 |
テバ ファーマシューティカル インダストリーズ リミテッド |
１−アミノインダン及びこれらの組成物
|
|
US5877218A
(en)
*
|
1994-01-10 |
1999-03-02 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
|
|
IL130528A
(en)
|
1996-12-18 |
2004-12-15 |
Teva Pharma |
Aminoindan derivatives, pharmaceutical compositions comprising them and uses thereof
|
|
US6737547B1
(en)
|
1998-12-31 |
2004-05-18 |
Teva Pharmaceutical Industries, Ltd. |
Compositions containing and methods of using N-acyl-1H-aminoindenes
|
|
US20040010038A1
(en)
*
|
2002-02-27 |
2004-01-15 |
Eran Blaugrund |
Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
|
|
EP1890690A4
(en)
*
|
2005-06-02 |
2010-06-02 |
Jenrin Discovery |
MAO-B INHIBITORS FOR TREATING OBESITY
|
|
WO2007061717A2
(en)
*
|
2005-11-17 |
2007-05-31 |
Teva Pharmaceutical Industries, Ltd. |
Methods for isolating propargylated aminoindans
|
|
BRPI0620659A2
(pt)
*
|
2005-12-09 |
2017-10-31 |
Yissum Res Dev Co Of Hebrew Univ Jerusalem Ltd |
método para a prevenção do aparecimento de sintomas de uma doença neurodegenerativa em um indivíduo predisposto à doença neurodegenerativa, método de redução de stress oxidante no cérebro de um indivíduo afligido com stress oxidante, método de tratamento de um indivíduo afligido com a degeneração cognitiva suave e composição farmacêutica
|
|
TW200744576A
(en)
*
|
2006-02-24 |
2007-12-16 |
Teva Pharma |
Propargylated aminoindans, processes for preparation, and uses thereof
|
|
EP2053033A1
(en)
|
2007-10-26 |
2009-04-29 |
Bayer Schering Pharma AG |
Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors
|
|
US8461388B2
(en)
|
2007-12-24 |
2013-06-11 |
Cipla Limited |
Process for the synthesis of propargylated aminoindan derivatives
|
|
EP2328861A2
(en)
*
|
2008-07-11 |
2011-06-08 |
Synthon BV |
Polymorphs of rasagiline hydrochloride
|
|
EP2358658A4
(en)
|
2008-11-20 |
2012-11-14 |
Reddys Lab Ltd Dr |
PREPARATION OF RASAGILIN AND ITS SALTS
|
|
PT2451771E
(pt)
*
|
2009-07-09 |
2014-09-19 |
Ratiopharm Gmbh |
Sais de rasagilina e suas preparações farmacêuticas
|
|
EP2325159A1
(en)
|
2009-11-24 |
2011-05-25 |
LEK Pharmaceuticals d.d. |
Novel salts of rasagiline
|
|
EP2610239A1
(en)
|
2012-01-02 |
2013-07-03 |
Dr. Reddy's Laboratories Ltd. |
Preparation Of Rasagiline Hemitartrate
|
|
EP3448519A4
(en)
*
|
2016-04-29 |
2020-01-22 |
Board Of Regents, The University Of Texas System |
SIGMA RECEIVER BINDERS
|